Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India

By Pharmaceutical Processing | October 28, 2009

Novavax, Inc. announced today that CPL Biologicals Pvt. Ltd., the new joint venturebetween Cadila Pharmaceuticals in India, has begun construction of astate-of-the-art manufacturing facility that will be used to produce pandemicand seasonal influenza vaccines. CPL Biologicals will utilize Novavax’svirus-like particle (VLP) vaccine technology to produce commercial-scalequantities of VLP-based influenza vaccines using Novavax’s innovativedisposable manufacturing solution. The CPL Biologicals facility is expectedto be operational within four months and should be capable of producing over60 million doses annually at full capacity. This facility will also be usedto produce other novel vaccines being developed by CPL Biologicals, based onNovavax’s VLP vaccine technology. “This new facility is being 100% supported financially by our partner,Cadila Pharmaceuticals Ltd. We anticipate creating sufficient capacity for CPLBiologicals to sell influenza vaccines in India and at the same time become apotential supplier to Novavax for sale of vaccines in other markets whereNovavax maintains complete commercial rights,” commented John Trizzino, SeniorVice President, International and Government Alliances for Novavax and InterimChief Executive Officer of CPL Biologicals. “We believe this model will showhow an efficient and scalable vaccine platform can help address the growingdemand for pandemic and seasonal influenza vaccines. Moreover, theconstruction of this manufacturing facility is consistent with Novavax’sstrategy to establish regional partnerships and regional manufacturingcapabilities that allow our VLP influenza vaccines to be licensed,manufactured and sold throughout the world.”

Related Articles Read More >

A Zipline fixed-wing drone in the air drops a package
Cardinal Health starts Zipline drone deliveries of drugs and medical supplies
Pfizer logo
Pfizer to spend $120M to make COVID-19 oral treatment in U.S.
Image of MedTrace Pharma's P3 automated delivery system for 15-O water in action
MedTrace Pharma moves forward on 15 O-water imaging tech
coronavirus COVID-19 Pfizer
NIH starts evaluating second COVID-19 booster shots in adults

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards